Kyungbin Moon

Dedicated Pharmacy Manager enthusiastic about helping diverse people and offering experience with regulatory requirements. Knowledgeable in medication management and pharmacy management. Bringing successful career history comprising more than three years. Also a capable pharmacist well-versed in collaborating with patients and healthcare team members to help alleviate symptoms and address root causes of medical issues. Experienced in calculating doses, preparing compounds, and securing storage to protect inventories.

• Licensed Pharmacist, Credential Number: PH61079615 - January 2021—Present
• Clinical Trials Certificate, University of Washington Department of Pharmacy: Biomedical Regulatory Affairs - June 2019
• Vaccinating Adults and Adolescents: An Immunization Program for Pharmacists - October 2016—Present
• ACPE Accredited Immunization Administration Training for Pharmacists - January 2023—Present
• CPR/AED for Healthcare Providers & First Aid Certification, American Heart Association - Renewal Date: September 2024
• International Yellow Fever Vaccination, State of Washington Department of Health- April 25, 2023—April 25, 2024

General Medicine

Harrison Medical Center

Preceptor: Angela Bottalico, PharmD, BCPS

• Inpatient pharmacy practice experiences in ICU, PCU, and hematology & oncology departments, including rounding, medication order reviews, and medication therapy recommendations
• Participated in weekly antibiotic stewardship meetings to provide antibiotic therapy recommendations and review Harrison Medical Center antibiotic therapy protocols

Clinic-Based Ambulatory Care

CHI Franciscan Health: Ambulatory Clinic
Preceptor: Kristin Peterson, PharmD, BCACP

• Anticoagulation clinic pharmacy practices, including INR interpretation, designing warfarin regimens, and direct oral anticoagulant therapy appointments
• Primary care pharmacy practices mainly focus on diabetes, hypertension, dyslipidemia, and cardiovascular diseases
• Participated in weekly journal club meetings for introducing and discussing pharmacotherapy-related topics, including elexacaftor/tezacaftor/ivacaftor for cystic fibrosis with a single phe508del allele treatment and anticoagulant therapies for bariatric surgery patients

Non-Profit Health Plan Managed Care

Premera Blue Cross

Preceptor: John Watkins, PharmD, MPH, BCPS

• Developed an initial drug review monograph for ITCA 650 (implantable exenatide in DUROS®, a mini-pump system) with potential formulary recommendations. The product remains in the pipeline and will be reviewed by the P&T committee in February 2020.
• Created recommendations and outlines for specialty drug prior authorization cases.
• Created a comprehensive table comparing various specialty drug policies of Premera and Express Scripts included in the Rare Conditions Value Programs, which was utilized for potential medical and pharmacy policies.

Government Agency

Washington State Health Care Authority

Preceptor: Ryan Pistoresi, PharmD, MS

• Created an SBAR for recommending an intra-articular steroid agent for managing osteoarthritis pain; the doctor who requested Zilretta accepted the recommendations for osteoarthritis pain treatment.
• Participated in medical journal evaluation method and strategies education session organized by Health Care Authority and Oregon Health & Science University to learn an advanced method for evaluating medical literature
• Attended strategic policymaking meetings, drug review meetings, and pharmaceuticals meetings to comprehend the agency, policy, and relationship with different health plans and pharmaceuticals

Pharmacy Benefit Management

OptumRx

Preceptor: Amy Lin, PharmD and Christopher Chiu, PharmD, BCPS

• Developed an initial drug review monograph for Slynd (drospirenone); further formulary consideration will be discussed at P&T meeting.
• Performed prior authorization evaluation and modeling of recently approved Parkinson’s Disease drugs, including Apokyn (apomorphine) and continuous subcutaneous injectable levodopa.
• Performed various OptumRx Utilization Management division tasks, including preparing drug monographs, creating drug management guidelines, and recommending drug formulations and tiers.